$166.03
-2.12[-1.26%]
Last update: 4:00PM (Delayed 15-Minutes)
Get Real Time Here
Get Real Time Here
$166.03
0[0.00%]
| Open168.120 | Close166.030 |
| Vol / Avg.127.444K / 334.280K | Mkt Cap6.254B |
| Day Range165.990 - 169.320 | 52 Wk Range159.730 - 245.000 |
Karuna Therapeutics Stock (NASDAQ:KRTX), Key Statistics
Karuna Therapeutics Stock (NASDAQ: KRTX) analysis, key statistics.
Valuation Measures
Enterprise Value
4.8B
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
972.66
Price / Book (mrq)
4.46
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-6.04%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
37.69
Tangible Book value per share
37.69
Total Liabilities (Quarterly)
52.5M
Total Assets
1.5B
Total Liabilities
52.5M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Karuna Therapeutics Stock (NASDAQ:KRTX), Key Statistics
Karuna Therapeutics Stock (NASDAQ: KRTX) analysis, key statistics.
Valuation Measures
Enterprise Value
4.8B
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
972.66
Price / Book (mrq)
4.46
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-6.04%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
37.69
Tangible Book value per share
37.69
Total Liabilities (Quarterly)
52.5M
Total Assets
1.5B
Total Liabilities
52.5M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Karuna Therapeutics Stock (NASDAQ:KRTX), Key Statistics
Karuna Therapeutics Stock (NASDAQ: KRTX) analysis, key statistics.
Valuation Measures
Enterprise Value
4.8B
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
972.66
Price / Book (mrq)
4.46
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-6.04%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
37.69
Tangible Book value per share
37.69
Total Liabilities (Quarterly)
52.5M
Total Assets
1.5B
Total Liabilities
52.5M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Karuna Therapeutics Stock (NASDAQ:KRTX), Key Statistics
Karuna Therapeutics Stock (NASDAQ: KRTX) analysis, key statistics.
Valuation Measures
Enterprise Value
4.8B
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
972.66
Price / Book (mrq)
4.46
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-6.04%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
37.69
Tangible Book value per share
37.69
Total Liabilities (Quarterly)
52.5M
Total Assets
1.5B
Total Liabilities
52.5M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Karuna Therapeutics Stock (NASDAQ:KRTX), Key Statistics
Karuna Therapeutics Stock (NASDAQ: KRTX) analysis, key statistics.
Valuation Measures
Enterprise Value
4.8B
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
972.66
Price / Book (mrq)
4.46
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-6.04%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
37.69
Tangible Book value per share
37.69
Total Liabilities (Quarterly)
52.5M
Total Assets
1.5B
Total Liabilities
52.5M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Karuna Therapeutics Stock (NASDAQ:KRTX), Key Statistics
Karuna Therapeutics Stock (NASDAQ: KRTX) analysis, key statistics.
Valuation Measures
Enterprise Value
4.8B
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
972.66
Price / Book (mrq)
4.46
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-6.04%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
37.69
Tangible Book value per share
37.69
Total Liabilities (Quarterly)
52.5M
Total Assets
1.5B
Total Liabilities
52.5M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Karuna Therapeutics Stock (NASDAQ:KRTX), Key Statistics
Karuna Therapeutics Stock (NASDAQ: KRTX) analysis, key statistics.
Valuation Measures
Enterprise Value
4.8B
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
972.66
Price / Book (mrq)
4.46
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-6.04%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
37.69
Tangible Book value per share
37.69
Total Liabilities (Quarterly)
52.5M
Total Assets
1.5B
Total Liabilities
52.5M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Karuna Therapeutics Stock (NASDAQ:KRTX), Key Statistics
Karuna Therapeutics Stock (NASDAQ: KRTX) analysis, key statistics.
Valuation Measures
Enterprise Value
4.8B
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
972.66
Price / Book (mrq)
4.46
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-6.04%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
37.69
Tangible Book value per share
37.69
Total Liabilities (Quarterly)
52.5M
Total Assets
1.5B
Total Liabilities
52.5M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Karuna Therapeutics Stock (NASDAQ:KRTX), Key Statistics
Karuna Therapeutics Stock (NASDAQ: KRTX) analysis, key statistics.
Valuation Measures
Enterprise Value
4.8B
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
972.66
Price / Book (mrq)
4.46
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-6.04%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
37.69
Tangible Book value per share
37.69
Total Liabilities (Quarterly)
52.5M
Total Assets
1.5B
Total Liabilities
52.5M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -